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Calcium channel blockers (CCB) are the leading cause of overdose death among all cardiovascular medicines [1]. Toxicity associated with CCBs may produce serious, life-
threatening complications, including bradycardia, dysrhythmias 
hypotension, metabolic acidosis, shock, or cardiovascular 
collapse. Intoxication with CCB has primarily been described for 
drugs such as diltiazem, verapamil, and nifedipine; whereas, there 
is limited clinical experience with amlodipine intoxication [2]. 
There are very few case reports from India related to amlodipine 
poisoning. We report a survival case of amlodipine intoxication 
with no other concomitant substance ingestion who is managed 
conservatively without using hyperinsulinemia euglycemic 
therapy.
CASE REPORT
A 25-year-old female nurse without any past medical or psychiatric 
history had suicidal ingestion of 20 tablets of 5 mg amlodipine. 
She had received gastric lavage within 30 minutes at the hospital 
where she was working. Then, she was shifted to Intensive 
cardiac care unit of our Institute. She had headache, abdominal 
pain, vomiting, fatigue, restlessness and was confused. She also 
had severe constipation for 3 days which improved later on. On 
presentation, her pulse was feeble with the rate of 100/min, the 
intra-arterial line showed BP of 68/46 mmHg. She was afebrile 
with the respiratory rate of 18/min, and normal jugular venous 
pressure. On cardiac examination, heart sounds were normal 
without any murmurs. The lungs were clear to auscultation. All 
other system examinations were within normal limits.
On routine blood examination, her hemoglobin was 9.7 g/dl, white 
blood cell count 23000 cells/mm3, neutrophils 88%, lymphocytes 
7%, and erythrocyte sedimentation rate 55 mm/h. Random blood 
sugar was 66 mg/dl for which intravenous (IV) dextrose 5% was 
given. Serum Na+ was 129 mEq/L, serum K+ 2.2 mEq/L, serum Ca++ 
6.9 mg/dL, and serum Mg++ 2.4 mg/dL but Renal and Liver function 
tests were within normal limits. ABG analysis showed metabolic 
acidosis with pH 7.25, PCO2 31.3 mmHg, PO2 121 mmHg, 
HCO3− 14 meq/L. IV potassium chloride, bicarbonate, and 
calcium gluconate were given to correct potassium, bicarbonate, 
and calcium levels, respectively. SPO2 was 84% for which 
intermittent continuous positive pressure ventilation was given. 
Electrocardiogram (ECG) shows sinus tachycardia with heart rate 
of 104/min, PR interval 140 ms, QRS interval 102 ms, QTc-394 ms, 
rSr in V1, ST depressions present in II, III, aVF, V2-V6 leads and ST 
elevation in aVR which mimics with myocardial infarction (Fig. 1). 
However, her cardiac enzymes (TropT and CK MB) were normal. 
Echocardiography shows normal left ventricular function without 
any regional wall motion abnormality.
She was given a rapid infusion of 1 L of IV fluid followed 
by maintenance infusion, but mean arterial blood pressure 
remained 55 mmHg. In addition, 10 ml of 10% calcium gluconate 
was administered every 15-20 min with ECG and serum 
calcium monitoring, but there was no improvement in arterial 
blood pressure. Dopamine was uptitrated to 15 μg/kg/min and 
noradrenaline 15 μg/min to increase the patient’s inotropy. 12 h 
later, the patient’s blood pressure increased to 80/56 mmHg 
and after 48 h blood pressure reached to 100/60 mmHg. Then, 
tapering of inotropes started and stopped on the 3rd day and 
patient was discharged in stable condition on the 6th day when 
her all symptoms relieved, electrolytes and ECG (Fig. 2) became 
normal. An informed written consent was taken from the patient 
for the publication of this case report.
ABSTRACT
Calcium channel blockers are commonly used in various cardiovascular diseases, but its poisoning may lead to fatal outcomes. 
We report a case of alleged poisoning of amlodipine in a 25-year-old female who consumed 20 tablets of 5 mg amlodipine. She 
presented with cardiogenic shock, hypoglycemia, hypokalemia, constipation, and central nervous system symptoms which were 
managed with intravenous crystalloids, calcium gluconate, 5% dextrose, dopamine, and noradrenaline infusion after which patient 
responded well and discharged.
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DISCUSSION
CCBs can be divided into two major categories: Dihydropyridines 
and nondihydropyridines. Dihydropyridines (e.g. Amlodipine) act 
preferentially on vascular smooth muscles and leads to relaxation. 
These drugs have little myocardial depressant activity at therapeutic 
levels and in fact, may increase cardiac output due to the reflex 
tachycardia. As dihydropyridines are smooth muscle selective, 
not smooth muscle-specific, in toxic concentrations they may lead 
to myocardial depression and impaired cardiac conduction. In 
addition, at high doses, they can block sodium channels and can 
cause QRS prolongation, similar to tricyclic antidepressants [3]. 
Intoxication with amlodipine results in nonspecific symptoms 
such as headache, nausea, vomiting, constipation, abdominal pain, 
dizziness, confusion and edema, and other non-specific symptoms.
The management of CCB overdose includes gastrointestinal 
decontamination with activated charcoal and total gut lavage 
with polyethylene glycol along with IV fluids, vasopressors; 
glucagon and/or calcium infusions [4]. Specific antidote is calcium 
gluconate or chloride. Other measures which can be tried include 
hyperinsulinemia-euglycemia therapy [5]. Some authors reported 
the use of vasopressin analogues in cases of hypotension due to 
sustained released calcium antagonists. In fact, using Terlipressin, 
hemodynamic stabilization could be achieved and the patient 
survived [6]. Hyperinsulinemic euglycemia in CCBs overdose 
was beneficial in several case reports. This approach was usually 
started after calcium gluconate and vasoactive drugs failure. Insulin 
acts by increasing plasma levels of ionized calcium, improving the 
hyperglycemic acidotic state, myocardial utilization of carbohydrates, 
and exerting its own independent inotropic effect [7]. However, we 
have not used hyperinsulinemic euglycemia as our patient presented 
with hypoglycemia and severe hypokalemia, which could have been 
worsened and may have detrimental effects. Although in patients 
with shock refractory to these therapies, anecdotal therapies have 
been tried with some success. These include continuous venovenous 
hemodiafiltration without charcoal hemoperfusion [8], IV lipid 
emulsion [9], levosimendan [10], methylene blue [11], intra-aortic 
balloon pump [12], and extracorporeal life support [13,14].
CONCLUSION
Early recognition, decontamination, IV fluids, calcium infusion, 
electrolytes correction, supportive measures such as inotropes and 
ventilation can successfully treat amlodipine intoxication. While 
in case of refractory shock, other new therapies can be considered.
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Figure 1: Electrocardiogram on presentation showing ST-T changes
Figure 2: Electrocardiogram at the time of discharge with resolution 
of ST-T changes
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